Genentech CEO Arthur Levinson - CEO pay report

Arthur Levinson - Genentech

Arthur Levinson

Total Compensation: $18.8 million

Details: Levinson declined a pay raise, keeping his base salary at $995K. He received $2.73 million in incentives and $9.77 million in stock option grants, bringing his total direct compensation to $13.9 million in 2007. His direct pay was $2.6 million lower than in 2006 due to the company's lower stock value in 2007.

Genentech News:
Genentech successes pay off big for CEO
Genentech touts pipeline as doubts fester
Genentech fights to keep edge in drug dev.

Genentech CEO Arthur Levinson - CEO pay report

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.